ArticleThe Journal of clinical investigation2021

TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis.

Zhou Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.